FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maura Brugiatelli

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Italy

Co-author Network

Publications

TOP 3
Massimo Federico; Vito Franco; Gianluca Gaidano; Sara Galimberti; stefano luminari; Luigi Marcheselli; Francesco Merli; Alessandro Pulsoni; Luigi Rigacci; Stefano Sacchi; Caterina Stelitano; Alessandra Tucci; Umberto Vitolo; Angelo Michele Carella; Matteo Dell'Olio; Francesco Di Raimondo; Alessandra Dondi; Francesco Angrilli; Luca Arcaini; Maura Brugiatelli
R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi.
Francesca Romana Mauro; Giovanna Meloni; Marco Montillo; Sante Tura; Pierluigi Zinzani; Giuseppe Bandini; Giovanni Barosi; Atto Billio; Maura Brugiatelli; Antonio Cuneo; Francesco Lauria; Vincenzo Liso; Monia Marchetti
SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia.
Luigi Marcheselli; Raffaella Marcheselli; Francesco Merli; Fortunato Morabito; Luca Baldini; Alessia Bari; Maura Brugiatelli; Nicola Di Renzo; Eliana Valentina Liardo; Stefano Sacchi
Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maura Brugiatelli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Massimo Federico; Vito Franco; Gianluca Gaidano; Sara Galimberti; stefano luminari; Luigi Marcheselli; Francesco Merli; Alessandro Pulsoni; Luigi Rigacci; Stefano Sacchi; Caterina Stelitano; Alessandra Tucci; Umberto Vitolo; Angelo Michele Carella; Matteo Dell'Olio; Francesco Di Raimondo; Alessandra Dondi; Francesco Angrilli; Luca Arcaini; Maura Brugiatelli
R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(12):1506-13.
2012: Francesca Romana Mauro; Giovanna Meloni; Marco Montillo; Sante Tura; Pierluigi Zinzani; Giuseppe Bandini; Giovanni Barosi; Atto Billio; Maura Brugiatelli; Antonio Cuneo; Francesco Lauria; Vincenzo Liso; Monia Marchetti
SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia.
Leukemia research 2012;36(4):459-66.
2011: Luigi Marcheselli; Raffaella Marcheselli; Francesco Merli; Fortunato Morabito; Luca Baldini; Alessia Bari; Maura Brugiatelli; Nicola Di Renzo; Eliana Valentina Liardo; Stefano Sacchi
Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma.
Leukemia & lymphoma 2011;52(10):1867-72.
2011: Stefano Molica; Francesca R Mauro; Diana Giannarelli; Francesco Lauria; Agostino Cortelezzi; Maura Brugiatelli; Vincenzo Liso; Antonio Cuneo; Robin Foà
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.
Haematologica 2011;96(2):277-83.
2010: Stefano Molica; Francesco Di Raimondo; Giovanna Cutrona; Sonia Fabris; Francesca Mauro; Maura Brugiatelli; Luca Baldini; Pellegrino Musto; Stefano Sacchi; Agostino Cortelezzi; Robert Foà; Antonino Neri; Massimo Federico; Manlio Ferrarini; Fortunato Morabito
Clinical categories identified by a new prognostic index reflect biological characteristics of patients in early chronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL) experience.
Leukemia research 2010;34(8):e217-8.
2010: Donato Mannina; stefano luminari; Alessandra Dondi; Giuseppe Polimeno; Luca Baldini; Caterina Stelitano; Francesco Merli; Matteo Dell'Olio; Paolo G Gobbi; Gianfranco Giglio; Elisa Barbolini; Maura Brugiatelli; Massimo Federico
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
Leukemia & lymphoma 2010;51(3):422-9.
2009: Emilio Iannitto; Viviana Minardi; Paolo G Gobbi; Giuseppina Calvaruso; Claudio Tripodo; Luigi Marcheselli; stefano luminari; Francesco Merli; Luca Baldini; Caterina Stelitano; Vincenzo Callea; Mario Petrini; Francesco Angrilli; Giovanni Quarta; Daniele Vallisa; Stefano Molica; Eliana Liardo; Giuseppe Polimeno; Maura Brugiatelli; Massimo Federico
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial.
Clinical lymphoma & myeloma 2009;9(2):138-44.
2009: Paolo G Gobbi; Francesco Valentino; Marco Danova; Fortunato Morabito; Bianca Rovati; Caterina Mammi; Massimo Gentile; Francesco Merli; Caterina Stelitano; stefano luminari; Gianni Quintana; Emilio Iannitto; Maura Brugiatelli; Massimo Federico
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.
Oncology reports 2009;21(4):1029-35.
2009: Massimo Federico; stefano luminari; Emilio Iannitto; Giuseppe Polimeno; Luigi Marcheselli; Antonella Montanini; Antonio La Sala; Francesco Merli; Caterina Stelitano; Samantha Pozzi; Renato Scalone; Nicola Di Renzo; Pellegrino Musto; Luca Baldini; Giulia Cervetti; Francesco Angrilli; Patrizio Mazza; Maura Brugiatelli; Paolo G Gobbi
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(5):805-11.
2008: Stefano Sacchi; Luigi Marcheselli; Alessia Bari; Raffaella Marcheselli; Samantha Pozzi; Paolo G Gobbi; Francesco Angrilli; Maura Brugiatelli; Pellegrino Musto; Massimo Federico
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.
Haematologica 2008;93(9):1335-42.
2008: Stefano Sacchi; Luigi Marcheselli; Alessia Bari; Raffaella Marcheselli; Samantha Pozzi; stefano luminari; Marco Lombardo; Gabriele Buda; antonio lazzaro; Paolo G Gobbi; Caterina Stelitano; Fortunato Morabito; Giovanni Quarta; Maura Brugiatelli
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Haematologica 2008;93(3):398-404.
2007: Massimo Federico; cesare guglielmi; stefano luminari; Caterina Mammi; Luigi Marcheselli; Umberto Gianelli; Antonio Maiorana; Francesco Merli; Monica Bellei; Samantha Pozzi; Caterina Stelitano; antonio lazzaro; Paolo G Gobbi; Luca Baldini; Stefania Bergantini; Vittorio Fregoni; Maura Brugiatelli
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study.
Haematologica 2007;92(11):1482-8.
2007: Stefano Sacchi; Samantha Pozzi; Raffaella Marcheselli; Massimo Federico; Alessandra Tucci; Francesco Merli; Lorella Orsucci; Marina Liberati; Daniele Vallisa; Maura Brugiatelli
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma.
Cancer 2007;110(1):121-8.
2007: Stefano Sacchi; Samantha Pozzi; Luigi Marcheselli; Alessia Bari; stefano luminari; Francesco Angrilli; Francesco Merli; Daniele Vallisa; Luca Baldini; Maura Brugiatelli
Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.
Cancer 2007;109(10):2077-82.
2007: Maura Brugiatelli; Barbara Loteta; Laura Nocilli; Donato Mannina
B-cell chronic lymphocytic leukemia: clinical impact of biological prognostic factors and updated treatment strategies.
Lijec̆nic̆ki vjesnik 2007;129 Suppl 3():26-8.
2006: Maura Brugiatelli; Giuseppe Bandini; Giovanni Barosi; Francesco Lauria; Vincenzo Liso; Monia Marchetti; Francesca Romana Mauro; Giovanna Meloni; Pier Luigi Zinzani; Sante Tura
Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 2006;91(12):1662-73.
2006: Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia Praticò; Caterina Stelitano; Vincenzo Callea; Fortunato Morabito; Eugenia Quartarone; Caterina Musolino; Eugenio Piro; Maura Brugiatelli; Pasquale Iacopino
High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients.
American journal of hematology 2006;81(12):973-8.
2006: Vincenzo Callea; Maura Brugiatelli; Caterina Stelitano; Massimo Gentile; Francesco Nobile; Fortunato Morabito
Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy.
Leukemia & lymphoma 2006;47(11):2314-20.
2006: Giuseppe Marotta; Antonio Frassoldati; Pier Luigi Zinzani; Luciana Annino; Maura Brugiatelli; Achille Ambrosetti; Mariapia Lenoci; Massimo Federico; Robin Foa; Francesco Lauria
Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.
European journal of haematology 2006;77(2):109-13.
2006: Massimo Federico; stefano luminari; Paolo G Gobbi; Stefano Sacchi; Nicola Di Renzo; Marco Lombardo; Francesco Merli; Luca Baldini; Caterina Stelitano; Giovanni Partesotti; Giuseppe Polimeno; Antonella Montanini; Caterina Mammi; Maura Brugiatelli
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study.
European journal of haematology 2006;76(3):217-29.
2006: Nicola Di Renzo; Maura Brugiatelli; Antonella Montanini; Maria Luigia Vigliotti; Giulia Cervetti; Anna Marina Liberati; stefano luminari; Pierangelo Spedini; Gianfranco Giglio; Massimo Federico
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.
Leukemia & lymphoma 2006;47(3):473-9.
2006: Fortunato Morabito; Caterina Stelitano; stefano luminari; Caterina Mammi; Luigi Marcheselli; Vincenzo Callea; Massimo Gentile; Giuseppe Polimeno; Francesco Merli; S Molica; P Gobbi; Francesco Angrilli; Maura Brugiatelli; Massimo Federico
The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Bone marrow transplantation 2006;37(3):283-8.
2005: Umberto Vitolo; Anna Marina Liberati; Maria Giuseppina Cabras; Massimo Federico; Emanuele Angelucci; Luca Baldini; Carola Boccomini; Maura Brugiatelli; Roberta Calvi; Giovannino Ciccone; Angelo Genua; Giorgio Lambertenghi Deliliers; Alessandro Levis; Guido Parvis; Enzo Pavone; Fabrizio Salvi; Marco Sborgia; Eugenio Gallo
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial.
Haematologica 2005;90(6):793-801.
2004: Silvana Capalbo; Vincenzo Callea; Caterina Musolino; Patrizia Guglielmo; Giovanni D'Arena; Alberto Fragasso; Cosima Battista; Rosario Giustolisi; Maura Brugiatelli; Vincenzo Liso
Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.
International journal of hematology 2004;79(4):354-7.
2004: Andrea Gallamini; Caterina Stelitano; Roberta Calvi; Monica Bellei; Daniele Mattei; Umberto Vitolo; Fortunato Morabito; Maurizio Martelli; Ercole Brusamolino; Emilio Iannitto; Francesco Zaja; Sergio Cortelazzo; Luigi Rigacci; liliana devizzi; Giuseppe Todeschini; Gino Santini; Maura Brugiatelli; Massimo Federico
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.
Blood 2004;103(7):2474-9.
2003: Luigi Rigacci; Massimo Federico; Maurizio Martelli; Pier Luigi Zinzani; Luigi Cavanna; Giampiero Bellesi; Francesco Merli; Renato Alterini; Maria Teresa Petrucci; Monica Tani; Anna Marina Liberati; Umberto Vitolo; Vincenzo Pavone; Antonio Cuneo; Teodoro Chisesib; Maura Brugiatelli
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases.
Leukemia & lymphoma 2003;44(11):1911-7.
2003: Massimo Federico; Monica Bellei; Pauline Brice; Maura Brugiatelli; Arnon Nagler; Christian Gisselbrecht; Luciano Moretti; Philippe Colombat; stefano luminari; Francesco Fabbiano; Nicola Di Renzo; Anthony Goldstone; Angelo Michele Carella
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2320-5.
2003: Luca Baldini; Maura Brugiatelli; stefano luminari; Marco Lombardo; Francesco Merli; Stefano Sacchi; Paolo G Gobbi; Marina Liberati; Luigi Cavanna; Mariangela Colombi; Caterina Stelitano; Maria Goldaniga; Fortunato Morabito; Massimo Federico; Vittorio Silingardi
Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1459-65.
2003: Giovanni D'Arena; Nicola Di Renzo; Maura Brugiatelli; Maria Luigia Vigliotti; Michael J Keating
Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia.
Leukemia & lymphoma 2003;44(2):223-8.
2002: Fortunato Morabito; Luca Baldini; Caterina Stelitano; stefano luminari; Antonio Frassoldati; Francesco Merli; Mariangela Colombi; Roberto Sabbatini; Maura Brugiatelli; Massimo Federico
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policy.
Leukemia & lymphoma 2002;43(10):1933-8.
2002: Marco Lombardo; Fortunato Morabito; Francesco Merli; Stefano Molica; Luigi Cavanna; Stefano Sacchi; Chiara Broglia; Francesco Angrilli; Fiorella Ilariucci; Caterina Stelitano; Dimitri Luisi; Raffaella Bertè; stefano luminari; Massimo Federico; Maura Brugiatelli
Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).
Leukemia & lymphoma 2002;43(9):1795-801.
2002: marco ladetto; Paolo Corradini; Sonia Vallet; Fabio Benedetti; Umberto Vitolo; Maurizio Martelli; Maura Brugiatelli; Paolo Coser; Alessio Perrotti; Ignazio Majolino; Giuseppe Fioritoni; Sergio Morandi; Maurizio Musso; Renato Zambello; Teodoro Chisesi; Nicola Di Renzo; Paolo Vivaldi; Alberto De Crescenzo; Andrea Gallamini; Fabrizio Salvi; Gino Santini; Carola Boccomini; Marco Sorio; Monica Astolfi; Daniela Drandi; Alessandro Pileri; Corrado Tarella
High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Blood 2002;100(5):1559-65.
2001: Fortunato Morabito; Massimo Mangiola; Bianca Maria Oliva; Caterina Stelitano; Vincenzo Callea; Silvia Deaglio; Pasquale Iacopino; Maura Brugiatelli; Fabio Malavasi
Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia.
Leukemia research 2001;25(11):927-32.
2001: Stefano Sacchi; Massimo Federico; Umberto Vitolo; Carola Boccomini; Daniele Vallisa; Luca Baldini; M Petrini; Serena Rupoli; Francesco Di Raimondo; Francesco Merli; V Liso; A Tabilio; Giuseppe Saglio; G Vinci; Maura Brugiatelli; Giuseppe Dastoli
Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma.
Haematologica 2001;86(9):951-8.
2001: Ozren Jaksic; Radovan Vrhovac; Rajko Kusec; M M Kardum; V Pandzic-Jaksic; Ika Kardum-Skelin; Ana Planinc-Peraica; F Morabito; Maura Brugiatelli; Branimir Jaksic
Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B-cell chronic lymphocytic leukemia.
Haematologica 2001;86(8):827-36.
2000: Caterina Stelitano; Luca Baldini; Carla Pieresca; Vincenzo Callea; Francesco Angrilli; V Clò; Giovanni Partesotti; Francesco Merli; Luigi Cavanna; Fortunato Morabito; Massimo Federico; Maura Brugiatelli; Vittorio Silingardi
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.
Haematologica 2000;85(2):154-9.
2000: Massimo Federico; Umberto Vitolo; Pier Luigi Zinzani; Teodoro Chisesi; V Clò; Giampiero Bellesi; M Magagnoli; Marina Liberati; Carola Boccomini; P Niscola; V Pavone; A Cuneo; Gino Santini; Maura Brugiatelli; Luca Baldini; Luigi Rigacci; Luigi Resegotti
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi.
Blood 2000;95(3):783-9.
1999: Vincenzo Callea; Fortunato Morabito; Bianca Maria Oliva; Caterina Stelitano; Domenico Levato; A Dattilo; F Gangemi; A Iorfida; Pasquale Iacopino; Francesco Nobile; Stefano Molica; Maura Brugiatelli
Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcome.
British journal of haematology 1999;107(2):347-52.
1999: Vincenzo Callea; Caterina Stelitano; Ida Callea; Giuseppe Console; Maura Brugiatelli; Fortunato Morabito
In vitro drug-induced cytotoxicity predicts clinical response to high-dose chlorambucil in B-cell chronic lymphocytic leukemia.
Haematologica 1999;84(9):863-4.
1999: Caterina Stelitano; Fortunato Morabito; M G Kropp; Vincenzo Callea; Francesco Iuliano; V Oriana; Domenico Levato; Francesco Nobile; Stefano Molica; Maura Brugiatelli
Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.
Haematologica 1999;84(4):317-23.
1998: Vincenzo Callea; V Clò; Fortunato Morabito; Luca Baldini; Caterina Stelitano; F Narni; P Avanzini; Maura Brugiatelli; Vittorio Silingardi
Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL).
Haematologica 1998;83(11):993-7.
1998: Massimo Federico; V Clò; Maura Brugiatelli; Mario Carotenuto; Paolo G Gobbi; Daniele Vallisa; Marco Lombardo; P Avanzini; Nicola Di Renzo; Daniele Dini; Luca Baldini; Vittorio Silingardi
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Haematologica 1998;83(9):800-11.
1998: Fortunato Morabito; Caterina Stelitano; Ida Callea; Antonella Dattola; Giuseppe Console; Giulia Pucci; Pasquale Iacopino; Vincenzo Callea; Francesco Di Raimondo; Maura Brugiatelli
In vitro drug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemia.
British journal of haematology 1998;102(2):528-31.
1997: Fortunato Morabito; Ida Callea; Giuseppe Console; Caterina Stelitano; G Sculli; M Filangeri; Bianca Maria Oliva; Caterina Musolino; Pasquale Iacopino; Maura Brugiatelli
The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemia.
Haematologica 1997;82(5):560-5.
1997: Branimir Jaksic; Maura Brugiatelli; I Krc; H Losonczi; J Holowiecki; Ana Planinc-Peraica; Rajko Kusec; F Morabito; Pasquale Iacopino; D Lutz
High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Cancer 1997;79(11):2107-14.
1997: Fortunato Morabito; Ida Callea; Giuseppe Irrera; G Cartisano; Antonella Dattola; A Rodinò; Maura Brugiatelli
In vitro improvement of chlorambucil-induced cytotoxicity by deflazacort and 6-methylprednisolone in B-cell chronic lymphocytic leukaemia.
European journal of haematology 1997;58(5):301-6.
1997: Maura Brugiatelli; J F Claisse; B Lenormand; Fortunato Morabito; Vincenzo Callea; K Malloum; Sylvie Chevret; Jacques-Louis Binet; Guillaume Dighiero; Philippe Travade
Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level.
British journal of haematology 1997;97(1):113-8.
1997: Fortunato Morabito; M Filangeri; Ida Callea; G Sculli; Vincenzo Callea; N S Fracchiolla; A Neri; Maura Brugiatelli
Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
Haematologica 1997;82(1):16-20.
1996: Maura Brugiatelli; B Holowiecka; A Dmoszynska; O Krieger; A Planinc-Peraica; Boris Labar; Vincenzo Callea; Fortunato Morabito; Branimir Jaksic; Jerzy Holowiecki; D Lutz
2-Chlorodeoxyadenosine treatment in non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy: results of a multicentric experience. International Society for Chemo-Immunotherapy.
Annals of hematology 1996;73(2):79-84.
1996: Vincenzo Callea; Fortunato Morabito; F Luise; A Piromalli; M Filangeri; Caterina Stelitano; Pasquale Iacopino; F Nobile; Maura Brugiatelli
Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia.
Haematologica 1996;81(4):310-5.
1996: Fortunato Morabito; Caterina Stelitano; Ida Callea; M Filangeri; Bianca Maria Oliva; G Sculli; Vincenzo Callea; F Nobile; Maura Brugiatelli
In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
Haematologica 1996;81(3):224-31.
1996: Stefano Molica; Pellegrino Musto; Federico Chiurazzi; G Specchia; Maura Brugiatelli; L Cicoira; Domenico Levato; F Nobile; Mario Carotenuto; Vincenzo Liso; Bruno Rotoli
Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.
Haematologica 1996;81(2):121-6.
1995: G Longo; Massimo Federico; Carla Pieresca; P Avanzini; Emilio Iannitto; A U Di Prisco; Luca Baldini; Maura Brugiatelli; V Clò; M Bevini
Anaplastic large cell lymphoma (CD30+/Ki-1+). Analysis of 35 cases followed at GISL centres.
European journal of cancer (Oxford, England : 1990) 1995;31A(11):1763-7.
1995: Maura Brugiatelli; Branimir Jaksic; A Planinc-Peraica; R Kusec; S Ostojic; Vincenzo Callea; Pasquale Iacopino; Fortunato Morabito; Caterina Stelitano; D Lutz
Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: long-term results of a randomized trial.
European journal of haematology 1995;55(3):158-63.
1995: Fortunato Morabito; Ida Callea; A Rodinò; Giuseppe Messina; Vincenzo Callea; Pasquale Iacopino; F Nobile; Maura Brugiatelli
Modulation of purine analogs- and chlorambucil-induced cytotoxicity by alpha-interferon and interleukin-2 in chronic lymphocytic leukemia.
Leukemia 1995;9(9):1450-5.
1994: Massimo Federico; Antonio Frassoldati; Teresa Lamparelli; R Foà; Maura Brugiatelli; Luciana Annino; Luca Baldini; G Capnist; Teodoro Chisesi; P F di Celle
Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(8):725-31.
1994: Stefano Molica; Maura Brugiatelli; Vincenzo Callea; Fortunato Morabito; Domenico Levato; F Nobile; A Alberti
Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases.
European journal of haematology 1994;52(4):216-21.
1993: Maura Brugiatelli; Massimo Federico; Paolo G Gobbi; P Avanzini; Vincenzo Callea; Luigi Cavanna; A De Pasquale; A U Di Prisco; N Di Rienzo; Vittorio Silingardi
Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentric randomized trial.
Haematologica 1993;78(5):306-12.
1993: Fortunato Morabito; Giuseppe Messina; Bianca Maria Oliva; F Ramirez; Vincenzo Callea; Maura Brugiatelli; F Nobile
In vitro chemosensitivity of chronic lymphocytic leukemia B-cells to multidrug regimen (CEOP) compounds using the MTT colorimetric assay.
Haematologica 1993;78(4):213-8.
1993: Fortunato Morabito; Vincenzo Callea; Bianca Maria Oliva; Caterina Stelitano; I Vincelli; Stefano Molica; A Alberti; Maura Brugiatelli; F Nobile
Alpha 2-interferon in B-cell chronic lymphocytic leukemia: clinical response, serum cytokine levels, and immunophenotype modulation.
Leukemia 1993;7(3):366-71.
1992: Stefano Molica; A Alberti; Maura Brugiatelli; Fortunato Morabito; Vincenzo Callea; F Nobile
Presenting features and prognosis of B-cell chronic lymphocytic leukemia patients less than 50 years old.
Blood 1992;79(11):3093-4.
1992: Jerzy Holowiecki; M Koehler; Z Zintl; G Kardos; D Lutz; S Krzemien; T Rewesz; Maura Brugiatelli; Vincenzo Callea; L Kachel
Childhood acute lymphoblastic leukemia immunophenotypes and their prognostic significance: experience of the IGCI-study in 389 children. International Society for Chemo-immunotherapy (IGCI-Vienna) Cooperative Group.
Leukemia & lymphoma 1992;7(3):225-34.
1992: Heinz Tüchler; S Hofmann; M Bernhart; Maura Brugiatelli; L Chrobak; A Franke; M Herold; Jerzy Holowiecki; R Ihle; Branimir Jaksic
A short multilingual quality of life questionnaire--practicability, reliability and interlingual homogeneity.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1992;1(2):107-17.
1989: A Neri; F Nobile; Maura Brugiatelli; Vincenzo Callea; Pasquale Iacopino; Bruno Martino; Fortunato Morabito; F Ronco
[Update on chronic lymphatic leukemia].
Haematologica 1989;74(5 Suppl):74-84.
1989: Maura Brugiatelli; Vincenzo Callea; Fortunato Morabito; Bianca Maria Oliva; P Francia Di Celle; Maria Teresa Fierro; A Neri; Robin Foa
Immunologic and molecular evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical remission phase.
Cancer 1989;63(10):1979-84.
1989: J Hołowiecki; D Lutz; Vincenzo Callea; Maura Brugiatelli; S Krzemień; B Stella-Hołowiecka; A Neri; R Ihle; V Schranz; F Graf
Expression of cell differentiation antigens as a prognostic factor in acute leukemia.
Haematology and blood transfusion 1989;32():104-8.
1989: A Neri; M Comis; Maura Brugiatelli; Bruno Martino; F Ronco
Aclacinomycin, cytosine arabinoside and thioguanine in relapsed or resistant acute myeloid leukemia.
Haematologica 1989;74(1):113-4.
1989: J Hołowiecki; D Lutz; S Krzemień; V Schranz; K Jagoda; B Hołowiecka; F Graf; G Kelenyi; Vincenzo Callea; Maura Brugiatelli
The expression of CD 15 antigen on myeloid leukaemia cells--a new prognostic index for complete remission and for survival.
Folia haematologica (Leipzig, Germany : 1928) 1989;116(2):289-95.
1988: B Jaksić; Maura Brugiatelli
High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL--IGCI CLL-01 trial.
Nouvelle revue française d'hématologie 1988;30(5-6):437-42.
1987: Fortunato Morabito; A Tassinari; Vincenzo Callea; Maura Brugiatelli; Maria Teresa Fierro; Giuseppe Saglio; A Neri; R Foà
Germ-line configuration of the T-cell receptor beta-chain gene in B-cell chronic lymphoproliferative disorders which co-express T-cell antigens.
European journal of haematology 1987;39(5):412-7.
1987: F Morabito; Vincenzo Callea; Maura Brugiatelli; D D'Ascola; A Palazzolo; A Neri
Non-Hodgkin's lymphoma associated with sickle cell disease: a case report.
Tumori 1987;73(5):523-4.
1987: Vincenzo Callea; V Trapani Lombardo; Maura Brugiatelli; C Latella; C Fragomeno; C Liotta; Bianca Maria Oliva; A Piromalli; A Neri
Immune status of hemophilia patients treated with concentrates. Study of 20 cases.
Haematologica 1987;72(4):323-8.
1987: J Hołowiecki; D Lutz; S Krzemień; F Graf; G Keleney; Maura Brugiatelli; Vincenzo Callea; B Hołowiecka; K Jagoda; R Ihle
Expression of CD-15 antigen on leukemic cells--a new prognostic factor for ability to achieve complete remission and for survival in ANLL.
Haematology and blood transfusion 1987;30():361-4.
1986: R Heinz; M Pawlicki; H Losonczy; M Varbiro; S Benedek; L Konopka; I Krc; Maura Brugiatelli
Initial chemotherapy with an age-adjusted CHOP-schedule in non-Hodgkin lymphomas with unfavorable prognosis. A study of the I.G.C.I.
Haematologica 1986;71(6):473-9.
1986: J Hołowiecki; D Lutz; S Krzemień; B Stella-Hołowiecka; F Graf; G Kelenyi; V Schranz; Vincenzo Callea; Maura Brugiatelli; A Neri
CD-15 antigen detected by the VIM-D5 monoclonal antibody for prediction of ability to achieve complete remission in acute nonlymphocytic leukemia.
Acta haematologica 1986;76(1):16-9.
1985: Maura Brugiatelli; Pasquale Iacopino; F Morabito; G Biagini
Hairy cell leukemia-like chronic lymphoproliferative disorder with nuclear extrusion.
Haematologica 1985;70(1):25-9.
1984: A Neri; Maura Brugiatelli; Pasquale Iacopino; Vincenzo Callea; F Ronco
Natural killer cell activity and T subpopulations in thalassemia major.
Acta haematologica 1984;71(4):263-9.
1982: A Neri; Maura Brugiatelli; M Comis; Pasquale Iacopino; Fortunato Morabito; F Nobile; F Ronco; V Trapani Lombardo; U Ozger Astaldi; G Astaldi
"In vitro" colony growth of blood T-lymphocytes from B-cell chronic lymphocytic leukemia.
Bollettino dell'Istituto sieroterapico milanese 1982;61(2):97-106.
1981: A Neri; Maura Brugiatelli; U Ozger Topuz; G Astaldi
Reduced natural killer cell activity in non-hodgkin's lymphoma.
Bollettino dell'Istituto sieroterapico milanese 1981;60(5):394-407.
1980: A Neri; G P Bagnara; G Biagini; F Nobile; M Comis; Laura Bonsi; P Preda; L Valvassori; Maura Brugiatelli; Fortunato Morabito; V T Lombardo; U O Topuz; M A Brunelli; G Astaldi
T-colonies in agar culture: clonal proliferation of T-progenitors or PHA-transformation of mature T-lymphocytes?
Bollettino dell'Istituto sieroterapico milanese 1980;59(3):211-9.
1980: Maura Brugiatelli; M Comis; Pasquale Iacopino; F Morabito; F Nobile; V Trapani Lombardo; A Neri
Multiple myeloma in husband and wife.
Acta haematologica 1980;64(4):227-9.